Analysis of the Reliability and Validity of the Chinese Version of CC-QoL

Sponsor
Guangzhou Institute of Respiratory Disease (Other)
Overall Status
Recruiting
CT.gov ID
NCT05362097
Collaborator
(none)
180
1
24
7.5

Study Details

Study Description

Brief Summary

At present, there is no research scale designed for the quality of life of children with chronic cough in China, most of them use the cough scale designed for adults to evaluate the quality of life of children. In China, more and more attention has been paid to evaluate and improve the quality of life of children with chronic cough, but cough specific quality of life measurement tools for adults and parents are mostly used, and the Chinese translation version of CQLQ and LCQ is still the main method. There is still no cough specific quality of life measurement tool for children with chronic cough in China. Cc-qol, a specific scale for chronic cough in children, has not been promoted, and no relevant verification of the applicability, validity and reliability of the Chinese version has been found. Therefore, this study aims to verify and compare the applicability, reliability and validity of CC-QOL Chinese version in China through questionnaire survey and follow-up of children with chronic cough.

Condition or Disease Intervention/Treatment Phase
  • Other: The reliability and validity of the Chinese version of CC-QoL

Detailed Description

Descriptive Score: CC-QOL, CET,VAS, Peds-QOL,SCAS and Verbal category Score (VCD); descriptive score: DESCRIPTIVE score; descriptive score: DESCRIPTIVE score; descriptive score: DESCRIPTIVE score; To evaluate the reliability and validity of Cc-QOL in evaluating children's quality of life in China, Compare and analyze Leicester cough questionnaire(LCQ) and child chronic cough-specific quality of life measure Cc-qol was used to evaluate the quality of life in children with chronic cough.

Study Design

Study Type:
Observational
Anticipated Enrollment :
180 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Analysis of the Reliability and Validity of the Chinese Version of Child Cough-specific Quality of Life Questionnaire(CC-QoL)
Anticipated Study Start Date :
May 5, 2022
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
May 5, 2024

Outcome Measures

Primary Outcome Measures

  1. Validity [At first visit, before medication, 2 weeks and 6 weeks after treatment initiation]

    Validity mainly evaluates the accuracy, validity and correctness of the scale, that is, the deviation between the measured value and the true target value.Validity is meant to reflect whether a measuring tool can effectively measure what it is intended to measure, that is, the extent to which the actual measured results agree with the expected results.

  2. Reliability [At first visit, before medication, 2 weeks and 6 weeks after treatment initiation]

    Reliability refers to the reliability, stability and consistency of the survey results, that is, accuracy.It is generally believed that reliability reflects the variation degree caused by measurement error or observation error, that is, random error.Common indicators: Common indicators: It is generally believed that Cronbach's alpha should be above 0.7. Retest reliability: the same questionnaire is used to measure the same group of respondents repeatedly at different times, and the consistency between the two results is retest reliability.

Secondary Outcome Measures

  1. Sensitivity [At first visit, before medication, 2 weeks and 6 weeks after treatment initiation]

    To evaluate the sensitivity of the questionnaire to measurements before and after treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 1.Age 7-14;

  • 2.Disease duration > 4 weeks;

  • 3.Spontaneous cough as the main or only clinical symptom。

Exclusion Criteria:
  • Chest X-ray was unremarkable, excluding cystic fibrosis, typical asthma or dyspnea, and other underlying diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guangzhou institute of respiratory disease Guangzhou Guangdong China 510120

Sponsors and Collaborators

  • Guangzhou Institute of Respiratory Disease

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
LI-HONG SUN, Professor, Guangzhou Institute of Respiratory Disease
ClinicalTrials.gov Identifier:
NCT05362097
Other Study ID Numbers:
  • GuangzhouIRD-LSUN3
First Posted:
May 5, 2022
Last Update Posted:
May 5, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by LI-HONG SUN, Professor, Guangzhou Institute of Respiratory Disease
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2022